Peptide News
Fact-checked peptide regulation and market news from the Peptide Bureau editorial desk. Last updated 22 October 2026.
What changed this week for research peptides and GLP-1 drugs in the United States: FDA decisions and warning letters, court cases, state actions, trial readouts and market moves. Two fact-checked pieces a week. Every fact links to the document it rests on, usually the FDA, the Federal Register, the Department of Justice or the company itself, and every piece also lands in the enforcement tracker when it is an enforcement action.
Latest
The FDA's Peptide 'Interim Access Policy' Is at the White House: What the Filing Shows and Who Has Asked to Meet on It
The FDA sent a peptide compounding policy to the White House on 14 October. What the filing shows, who has asked to meet on it, and what is still unknown.
Read ›Black-Market Retatrutide: Two Death Reports to the FDA, Rising Poison Center Calls and Five More Lilly Lawsuits
Two deaths reported to the FDA after bootleg retatrutide, 862 poison center exposures in a quarter, five new Lilly suits. What is verified and what is not.
Read ›Are Peptides Legal Now? The Reported 'Temporary Sale' Plan, Checked Against the Record
No FDA order exists yet. What the Washington Post reported on 7 October, what it would cover, why research-use vendors are not part of it, what to watch.
Read ›Standing coverage
Peptide and GLP-1 enforcement tracker
Every FDA warning letter, DOJ case, lawsuit and state action against peptide and GLP-1 sellers since 2025, each linked to its source.
Open ›The FDA advisory committee peptide vote, July 2026
Every tally from the PCAC vote on BPC-157, TB-500, KPV, MOTS-c, Semax, Epitalon and DSIP, and what it does and does not change.
Open ›Are peptides legal in the US?
Federal law first, then all 50 states, kept current as the FDA's position moves.
Open ›Peptide law by state: free dataset
All 50 states and every federal action as CSV and JSON, each row with its source, free to reuse under CC BY 4.0.
Open ›Peptide vendor shutdowns in 2026
Which research peptide vendors closed or stopped shipping this year, and what the record shows about why.
Open ›